130 related articles for article (PubMed ID: 6466387)
21. Serotonin-sensitive adenylate cyclase in neural tissue and its similarity to the serotonin receptor: a possible site of action of lysergic acid diethylamide.
Nathanson JA; Greengard P
Proc Natl Acad Sci U S A; 1974 Mar; 71(3):797-801. PubMed ID: 4595572
[TBL] [Abstract][Full Text] [Related]
22. Effect of adenylate cyclase activators and Mg2+ on the binding and the electron spin resonance spectra of N-methylmaleimide nitroxide in membrane particles from the liver fluke Fasciola hepatica.
Du ZH; Mansour TE
Biochim Biophys Acta; 1982 May; 687(2):257-64. PubMed ID: 6284221
[TBL] [Abstract][Full Text] [Related]
23. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
[TBL] [Abstract][Full Text] [Related]
24. [Increase in binding affinity of the 5-HT receptor and decrease in 5-HT sensitive adenylate cyclase activity following prolonged exposure to 5-HT (author's transl)].
Fillion G; Fillion MP; Rousselle JC
J Physiol (Paris); 1981; 77(2-3):363-8. PubMed ID: 7288651
[TBL] [Abstract][Full Text] [Related]
25. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
Unsworth CD; Molinoff PB
J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
[TBL] [Abstract][Full Text] [Related]
27. Serotonin-elicited amplification of adenylate cyclase activity in hippocampal membranes from adult rat.
Barbaccia ML; Brunello N; Chuang DM; Costa E
J Neurochem; 1983 Jun; 40(6):1671-9. PubMed ID: 6854325
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
[TBL] [Abstract][Full Text] [Related]
29. Photoreactivity of lysergic acid diethylamide and its possible utility as a photoaffinity labeling reagent.
Walker EB; McNall SJ; Mansour TE
Biochem Pharmacol; 1983 Apr; 32(7):1251-7. PubMed ID: 6847715
[TBL] [Abstract][Full Text] [Related]
30. Serotonin-activated adenylate cyclase from Fasciola hepatica. Properties of the solubilized enzyme.
Northup JK; Renart MF; Grove JR; Mansour TE
J Biol Chem; 1979 Dec; 254(23):11861-7. PubMed ID: 500679
[No Abstract] [Full Text] [Related]
31. Adenosine cyclic 3',5'-monophosphate in the liver fluke, Fasciola hepatica. II. Activation of protein kinase by 5-hydroxytryptamine.
Gentleman S; Abrahams SL; Mansour TE
Mol Pharmacol; 1976 Jan; 12(1):59-68. PubMed ID: 176568
[No Abstract] [Full Text] [Related]
32. Nature of serotonin-activated adenylate cyclase during development of Schistosoma mansoni.
Estey SJ; Mansour TE
Mol Biochem Parasitol; 1987 Nov; 26(1-2):47-59. PubMed ID: 3431567
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of a 5-HT receptor in locust nervous tissue.
Wedemeyer S; Roeder T; Gewecke M
Eur J Pharmacol; 1992 Nov; 223(2-3):173-8. PubMed ID: 1362163
[TBL] [Abstract][Full Text] [Related]
35. Multiple serotonin receptors and their physiological significance.
Peroutka SJ; Snyder SH
Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
[TBL] [Abstract][Full Text] [Related]
36. Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.
MacDermot J; Higashida H; Wilson SP; Matsuzawa H; Minna J; Nirenberg M
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1135-9. PubMed ID: 220607
[TBL] [Abstract][Full Text] [Related]
37. Phosphofructokinase from the liver fluke Fasciola hepatica. i. Activation by adenosine 3',5'-phosphate and by serotonin.
Stone DB; Mansour TE
Mol Pharmacol; 1967 Mar; 3(2):161-76. PubMed ID: 4226783
[No Abstract] [Full Text] [Related]
38. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
39. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
Ahn HS; Makman MH
Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
[TBL] [Abstract][Full Text] [Related]
40. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.
Meibach RC; Maayani S; Green JP
Eur J Pharmacol; 1980 Oct; 67(4):371-82. PubMed ID: 7449822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
